Fas ligand: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
 
CSV import
 
(2 intermediate revisions by the same user not shown)
Line 1: Line 1:
'''Fas ligand''' (also known as '''FasL''', '''CD95L''', or '''CD178''') is a type-1 transmembrane protein that belongs to the [[tumor necrosis factor (TNF) family]]. It binds with the [[Fas receptor]] (CD95) to induce apoptosis, a process of programmed cell death. Fas ligand plays a crucial role in the regulation of the immune system and the progression of cancer.
= Fas Ligand =
 
[[File:Fas_signaling.jpg|thumb|right|Diagram of Fas signaling pathway]]
 
'''Fas ligand''' ('''FasL''') is a type-II transmembrane protein that belongs to the [[tumor necrosis factor]] (TNF) family. It plays a crucial role in the regulation of the [[immune system]] and the induction of [[apoptosis]]. Fas ligand is primarily expressed on the surface of activated [[T cells]] and [[natural killer cells]].


== Structure ==
== Structure ==
Fas ligand is a type-II transmembrane protein, which means it has an extracellular C-terminal domain and a cytoplasmic N-terminal domain. The extracellular domain of Fas ligand is what interacts with the Fas receptor. The cytoplasmic domain is not required for apoptosis induction.
Fas ligand is a homotrimeric protein, meaning it forms a complex of three identical subunits. Each subunit consists of an extracellular domain, a transmembrane domain, and a short cytoplasmic tail. The extracellular domain is responsible for binding to its receptor, [[Fas receptor]] (also known as CD95), which is a member of the TNF receptor superfamily.


== Function ==
== Function ==
The primary function of Fas ligand is to bind to the Fas receptor and initiate a series of events that lead to apoptosis. This process is critical for the regulation of the immune system. It helps to maintain immune homeostasis and prevent autoimmune diseases by killing off excess or harmful cells.
Fas ligand is involved in the induction of apoptosis, a form of programmed cell death. When Fas ligand binds to the Fas receptor on the surface of a target cell, it triggers a cascade of intracellular signaling events that lead to cell death. This process is essential for maintaining immune system homeostasis and preventing autoimmune diseases.
 
=== Apoptosis Induction ===
Upon binding of Fas ligand to Fas receptor, the receptor trimerizes and recruits the adaptor protein [[FADD]] (Fas-associated death domain). FADD then recruits [[procaspase-8]], forming the death-inducing signaling complex (DISC). Activation of procaspase-8 leads to the activation of downstream effector caspases, such as caspase-3, ultimately resulting in apoptosis.


Fas ligand is also involved in immune privilege, a state in which certain body sites are able to tolerate the introduction of antigens without eliciting an inflammatory immune response. This is achieved by Fas ligand-mediated apoptosis of invading immune cells.
[[File:Signal_transduction_pathways.svg|thumb|left|Overview of signal transduction pathways, including Fas signaling]]


== Role in Disease ==
== Role in the Immune System ==
Alterations in the Fas ligand/Fas receptor system can lead to various diseases. For example, mutations in the Fas ligand or Fas receptor can cause autoimmune lymphoproliferative syndrome (ALPS), a rare disorder characterized by non-malignant lymphoproliferation, autoimmunity, and increased risk of lymphoma.
Fas ligand is critical for the regulation of the immune response. It is involved in the elimination of activated [[lymphocytes]] and the maintenance of [[immune privilege]] in certain tissues, such as the [[eye]] and [[testis]]. Fas ligand-mediated apoptosis is also important for the deletion of autoreactive T cells in the [[thymus]], preventing the development of autoimmune diseases.


In cancer, Fas ligand expression can be a double-edged sword. On one hand, cancer cells can use Fas ligand to kill attacking immune cells and evade the immune response. On the other hand, therapies that enhance Fas ligand expression can be used to kill cancer cells.
== Clinical Significance ==
Dysregulation of Fas ligand expression or function can lead to various pathological conditions. Overexpression of Fas ligand can contribute to tissue damage in [[autoimmune diseases]], while insufficient Fas ligand activity can result in the accumulation of autoreactive lymphocytes. Mutations in the Fas or Fas ligand genes are associated with autoimmune lymphoproliferative syndrome (ALPS), a disorder characterized by lymphadenopathy, splenomegaly, and autoimmune cytopenias.


== See Also ==
== Related Pages ==
* [[Apoptosis]]
* [[Apoptosis]]
* [[Fas receptor]]
* [[Fas receptor]]
* [[Tumor necrosis factor (TNF) family]]
* [[Tumor necrosis factor]]
* [[Autoimmune lymphoproliferative syndrome (ALPS)]]
* [[Immune system]]
* [[Immune privilege]]
* [[Autoimmune disease]]


== References ==
{{Tumor necrosis factor ligand family}}
<references />


[[Category:Proteins]]
[[Category:Immunology]]
[[Category:Cell biology]]
[[Category:Apoptosis]]
[[Category:Apoptosis]]
{{Protein-stub}}
[[Category:Immune system]]
{{Immunology-stub}}
[[Category:Signal transduction]]

Latest revision as of 14:23, 21 February 2025

Fas Ligand[edit]

Diagram of Fas signaling pathway

Fas ligand (FasL) is a type-II transmembrane protein that belongs to the tumor necrosis factor (TNF) family. It plays a crucial role in the regulation of the immune system and the induction of apoptosis. Fas ligand is primarily expressed on the surface of activated T cells and natural killer cells.

Structure[edit]

Fas ligand is a homotrimeric protein, meaning it forms a complex of three identical subunits. Each subunit consists of an extracellular domain, a transmembrane domain, and a short cytoplasmic tail. The extracellular domain is responsible for binding to its receptor, Fas receptor (also known as CD95), which is a member of the TNF receptor superfamily.

Function[edit]

Fas ligand is involved in the induction of apoptosis, a form of programmed cell death. When Fas ligand binds to the Fas receptor on the surface of a target cell, it triggers a cascade of intracellular signaling events that lead to cell death. This process is essential for maintaining immune system homeostasis and preventing autoimmune diseases.

Apoptosis Induction[edit]

Upon binding of Fas ligand to Fas receptor, the receptor trimerizes and recruits the adaptor protein FADD (Fas-associated death domain). FADD then recruits procaspase-8, forming the death-inducing signaling complex (DISC). Activation of procaspase-8 leads to the activation of downstream effector caspases, such as caspase-3, ultimately resulting in apoptosis.

Overview of signal transduction pathways, including Fas signaling

Role in the Immune System[edit]

Fas ligand is critical for the regulation of the immune response. It is involved in the elimination of activated lymphocytes and the maintenance of immune privilege in certain tissues, such as the eye and testis. Fas ligand-mediated apoptosis is also important for the deletion of autoreactive T cells in the thymus, preventing the development of autoimmune diseases.

Clinical Significance[edit]

Dysregulation of Fas ligand expression or function can lead to various pathological conditions. Overexpression of Fas ligand can contribute to tissue damage in autoimmune diseases, while insufficient Fas ligand activity can result in the accumulation of autoreactive lymphocytes. Mutations in the Fas or Fas ligand genes are associated with autoimmune lymphoproliferative syndrome (ALPS), a disorder characterized by lymphadenopathy, splenomegaly, and autoimmune cytopenias.

Related Pages[edit]

Template:Tumor necrosis factor ligand family